Carregant...
Disease duration as an indicator of the efficacy of liraglutide in patients with type 2 diabetes mellitus
Comment on the article of Usui et al. Retrospective cohort study of obese patients with type 2 diabetes mellitus (n = 69) demonstrates that the glucose‐lowering effect of liraglutide as add on therapy to insulin relies on the remaining beta‐cell function in type 2 diabetes. Shorter disease duration...
Guardat en:
| Publicat a: | J Diabetes Investig |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6031510/ https://ncbi.nlm.nih.gov/pubmed/29974671 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12857 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|